Conclusion—Recommendation: Antiplatelet drugs should not be routinely initiated for thromboprophylaxis and concomitant administration with anticoagulants should be considered on an individualized basis, taking into consideration the indication for antiplatelet treatment and the thrombotic/bleeding risk of each patient.